ophthalmic solution
Showing 1 - 25 of 5,694
Healthy Adult Males Volunteers Trial in Osaka (STN1012600 ophthalmic solution 0.002%)
Recruiting
- Healthy Adult Males Volunteers
- STN1012600 ophthalmic solution 0.002%
-
Osaka, JapanMedical Corporation Heishinkai OPHAC Hospital
Jun 6, 2023
Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca Trial (5% Tavilermide ophthalmic solution, Vehicle ophthalmic
Not yet recruiting
- Dry Eye Syndromes
- +2 more
- 5% Tavilermide ophthalmic solution
- Vehicle ophthalmic solution
- (no location specified)
Apr 27, 2023
Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))
Not yet recruiting
- Dry Eye Syndromes
- IC265 Ophthalmic Solution 1%
- Placebo Ophthalmic Solution (Vehicle)
-
Andover, MassachusettsIacta Selected Site
Aug 8, 2023
Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)
Not yet recruiting
- Dry Eye Disease
- Topical spironolactone ophthalmic solution, 0.005 mg/cc
- Placebo
-
Bellaire, TexasRichard W Yee, MD PLLC
Aug 16, 2023
Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)
Recruiting
- Corneal Epithelial Degeneration
- TTHX1114(NM141) Ophthalmic Solution
-
Cypress, CaliforniaTrefoil Clinical Site #132
Mar 3, 2023
Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)
Recruiting
- Allergic Conjunctivitis
- MDI-1228_mesylate Ophthalmic Solution
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jul 24, 2023
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost
Not yet recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- Travoprost Ophthalmic Topical Cream low-dose
- +4 more
-
Newport Beach, CaliforniaGlaukos Clinical Study Site
Nov 22, 2023
Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)
Completed
- Dry Eye Disease
- Reproxalap Ophthalmic Solution (0.25%)
- Placebo Comparator
-
Andover, MassachusettsAndover Eye Associates
Jan 24, 2023
Open Angle Glaucoma Trial (NCX 470, Placebo)
Not yet recruiting
- Open Angle Glaucoma
- NCX 470
- Placebo
- (no location specified)
Jul 6, 2023
Cataract, Glaucoma, Ocular Hypertension Trial in Glendale (Bimatoprost Implant System (High Dose), Bimatoprost Implant System
Recruiting
- Cataract
- +2 more
- Bimatoprost Implant System (High Dose)
- +4 more
-
Glendale, ArizonaArizona Advanced Eye Research Institute
Nov 8, 2023
0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in
Not yet recruiting
- Post Operative Endophthalmitis
- Moxifloxacin hydrochloride ophthalmic solution
- (no location specified)
Jan 11, 2023
Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial
Not yet recruiting
- Primary Open Angle Glaucoma (POAG)
- +3 more
- Experimental: QLS-111 ophthalmic solution, (0.015%)
- +4 more
- (no location specified)
Aug 30, 2023
Rhegmatogenous Retinal Detachment - Macula Off Trial (ONL1204 Ophthalmic Solution, Sham treatment)
Not yet recruiting
- Rhegmatogenous Retinal Detachment - Macula Off
- ONL1204 Ophthalmic Solution
- Sham treatment
- (no location specified)
Feb 15, 2023
Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)
Recruiting
- Presbyopia
- 0.1% STN1013600 ophthalmic solution
- +2 more
-
Glendale, California
- +1 more
Jan 12, 2023
Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution
Recruiting
- Dry Eye Disease
- SY-201 Ophthalmic Solution 2.0%
- +3 more
-
Durham, North CarolinaLexitas
Jul 27, 2022
Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,
Not yet recruiting
- Allergic Conjunctivitis
- Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
- +3 more
-
Phoenix, Arizona
- +2 more
Nov 9, 2022
Neurotrophic Keratitis Trial (BRM424 Ophthalmic Solution, Vehicle)
Not yet recruiting
- Neurotrophic Keratitis
- BRM424 Ophthalmic Solution
- Vehicle
- (no location specified)
Jun 28, 2023
Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution
Recruiting
- Open Angle Glaucoma, Ocular Hypertension
- STN1012600 ophthalmic solution 0.002%
- STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
-
Aichi, Japan
- +15 more
Aug 16, 2022
Epiphora, Dacryostenosis, Dacryocystitis Trial in New Orleans (Proparacaine Hydrochloride ophthalmic solution, USP 0.5%,
Recruiting
- Epiphora
- +2 more
- Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
- Balanced salt solution
-
New Orleans, LouisianaLouisiana State University Health Sciences Center
Dec 15, 2022
Dry Eye Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Xiidra® (5% lifitegrast ophthalmic solution))
Completed
- Dry Eye
- Reproxalap Ophthalmic Solution (0.25%)
- Xiidra® (5% lifitegrast ophthalmic solution)
-
Mississauga, Ontario, CanadaCliantha Research
Sep 26, 2022
Preservative-Free Ophthalmic Solution in Ocular Dryness
Active, not recruiting
- Dry Eye Syndromes
- Eyestil SYNFO
-
Alicante, Spain
- +3 more
Mar 20, 2023
Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic
Not yet recruiting
- Seasonal Allergic Conjunctivitis
- Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
- +3 more
-
Andover, Massachusetts
- +1 more
Nov 9, 2022
Anesthesia, Local Trial in McAllen (AG-920, Proparacaine Ophthalmic)
Completed
- Anesthesia, Local
- AG-920
- Proparacaine Ophthalmic
-
McAllen, TexasAmerican Genomics Site 2
Sep 21, 2022